WEDNESDAY, Sept. 9, 2026 — A drug that heart doctors widely expected to become the next major weapon against heart attacks has failed in a large clinical trial, drugmaker Novartis announced.
The experimental drug, pelacarsen, did lower blood…
Blog
Leave a Reply